Development of the CHARIOT research register for the prevention of Alzheimer's dementia and other late onset neurodegenerative diseases

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Larsen, Mark E ^a   Curry, Lisa ^a   Mastellos, Nikolaos ^a   Robb, Catherine ^a   Car, Josip ^a,b   Middleton, Lefkos T ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; CHARIOT RESEARCH REGISTER; CONTROLLED STUDY; DATA ANALYSIS; DEGENERATIVE DISEASE; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE REGISTRY; ETHNICITY; FEMALE; HEALTH PROGRAM; HISTORY; HUMAN; LATE ONSET DISORDER; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MIDDLE AGED; NEUROPROTECTION; OUTCOME ASSESSMENT; PROCESS DEVELOPMENT; SEX DIFFERENCE; SOCIAL STATUS; VERY ELDERLY; DEMENTIA; ETHNIC GROUP; ONSET AGE; REGISTER;

AGE DISTRIBUTION; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DEMENTIA; ETHNIC GROUPS; FEMALE; HUMANS; MALE; REGISTRIES;

EID: 84957999157     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0141806     Document Type: Article

References (37)

1. World Health Organization. World Health Organization. Dementia cases set to triple by 2050 but still largely ignored 2012. Available from: http://www.who.int/mediacentre/news/releases/2012/dementia- 20120411/en/index.html.
2. Wimo A, Jonsson L, Bond J, Prince M, Winblad B, Alzheimer Disease I. The worldwide economic impact of dementia 2010. Alzheimer's & dementia: the journal of the Alzheimer's Association. 2013; 9 (1):1-11 e3. doi: 10.1016/j.jalz.2012.11.006 PMID: 23305821.
3. James BD, Leurgans SE, Hebert LE, Scherr PA, Yaffe K, Bennett DA. Contribution of Alzheimer disease to mortality in the United States. Neurology. 2014; 82(12):1045-50. doi: 10.1212/WNL. 0000000000000240 PMID: 24598707; PubMed Central PMCID: PMC3962992.
4. Department of Health. The Dementia Challenge: Areas for Action-Improving Research 2012. Available from: http://dementiachallenge.dh.gov.uk/category/areas-for-action/research/.
5. Ousset P-J, Cummings J, Delrieu J, Legrand V, Prins N, Winblad B, et al. Is Alzheimer's disease drug development broken? What must be improved. J Prev Alz Dis. 2014; 1(1):40-5.
6. Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. The New England journal of medicine. 2012; 367 (9):795-804. doi: 10.1056/NEJMoa1202753 PMID: 22784036; PubMed Central PMCID: PMC3474597.
7. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer's disease. Alzheimer's & dementia: the journal of the Alzheimer's Association. 2007; 3(3):186-91. doi: 10.1016/j.jalz.2007.04.381 PMID: 19595937.
8. Amieva H, Le Goff M, Millet X, Orgogozo JM, Peres K, Barberger-Gateau P, et al. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms. Annals of neurology. 2008; 64(5):492-8. doi: 10.1002/ana.21509 PMID: 19067364.
9. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, et al. Revising the definition of Alzheimer's disease: a new lexicon. The Lancet Neurology. 2010; 9(11):1118-27. doi: 10.1016/S1474-4422(10)70223-4 PMID: 20934914.
10. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & dementia: the journal of the Alzheimer's Association. 2011; 7(3):280-92. doi: 10.1016/j.jalz.2011.03.003 PMID: 21514248; PubMed Central PMCID: PMC3220946.
11. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & dementia: the journal of the Alzheimer's Association. 2011; 7(3):270-9. doi: 10.1016/j.jalz.2011.03.008 PMID: 21514249; PubMed Central PMCID: PMC3312027.
12. Bell-Syer SEM, Moffett JAK. Recruiting patients to randomized trials in primary care: principles and case study. Fam Pract. 2000; 17(2):187-91. doi: 10.1093/fampra/17.2.187 PMID: WOS:000086534600016.
13. Bower P, Wilson S, Mathers N. Short report: How often do UK primary care trials face recruitment delays? Fam Pract. 2007; 24(6):601-3. doi: 10.1093/fampra/cmm051 PMID: WOS:000251866100012.
14. Hetherton J, Matheson A, Robson M. Recruitment by GPs during consultations in a primary care randomized controlled trial comparing computerized psychological therapy with clinical psychology and routine GP care: problems and possible solutions. Prim Health Care Res Dev. 2004; 5:5-10.
15. Mason VL, Shaw A, Wiles NJ, Mulligan J, Peters TJ, Sharp D, et al. GPs' experiences of primary care mental health research: a qualitative study of the barriers to recruitment. Fam Pract. 2007; 24(5):518-25. doi: 10.1093/fampra/cmm047 PMID: WOS:000251035700018.
16. Bower P, Wallace P, Ward E, Graffy J, Miller J, Delaney B, et al. Improving recruitment to health research in primary care. Fam Pract. 2009; 26(5):391-7. doi: 10.1093/fampra/cmp037 PMID: WOS:000269950100010.
17. Gill TM, McGloin JM, Gahbauer EA, Shepard DM, Bianco LM. Two recruitment strategies for a clinical trial of physically frail community-living older persons. Journal of the American Geriatrics Society. 2001; 49(8):1039-45. PMID: 11555064.
18. Patel MX, Doku V, Tennakoon L. Challenges in recruitment of research participants. Adv Psychiatr Treat. 2003; 9:229-38.
19. Vellas B, Hampel H, Rouge-Bugat ME, Grundman M, Andrieu S, Abu-Shakra S, et al. Alzheimer's disease therapeutic trials: EU/US Task Force report on recruitment, retention, and methodology. The journal of nutrition, health & aging. 2012; 16(4):339-45. PMID: 22499454.
20. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002; 360(9326):7-22. doi: 10.1016/S0140-6736(02)09327-3 PMID: 12114036.
21. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. Jama. 2003; 289(20):2651-62. doi: 10.1001/jama.289.20.2651 PMID: 12771112.
22. Adapt Research Group, Lyketsos CG, Breitner JC, Green RC, Martin BK, Meinert C, et al. Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology. 2007; 68(21):1800-8. doi: 10.1212/01.wnl.0000260269.93245.d2 PMID: 17460158.
23. Sano M, Jacobs D, Andrews H, Bell K, Graff-Radford N, Lucas J, et al. A multi-center, randomized, double blind placebo-controlled trial of estrogens to prevent Alzheimer's disease and loss of memory in women: design and baseline characteristics. Clinical trials. 2008; 5(5):523-33. doi: 10.1177/1740774508096313 PMID: 18827045; PubMed Central PMCID: PMC3884686.
24. Iliffe S, Curry L, Kharicha K, Rait G, Wilcock J, Lowery D, et al. Developing a Dementia Research Registry: a descriptive case study from North Thames DeNDRoN and the EVIDEM programme. BMC medical research methodology. 2011; 11(1):9. doi: 10.1186/1471-2288-11-9 PMID: 21272296; PubMed Central PMCID: PMC3038162.
25. Alzheimer's Prevention Registry. Available from: http://www.endalznow.org.
26. Health & Social Care Information Centre. Quality and Outcomes Framework. Available from: http://www.hscic.gov.uk/qof.
27. Public Health England. National General Practice Profiles. Available from: http://www.apho.org.uk.
28. Olsson T, Alexander R, Haeberlein SB, Hannesdottir K, Andrews T, Curry L, et al. Use of a telephone interview methodology to identify subjects with cognitive impairment among those reporting subjective memory complaints. AD/PD Conference; 18-22 March; France2015.
29. Galvin JE, Roe CM, Powlishta KK, Coats MA, Muich SJ, Grant E, et al. The AD8: a brief informant interview to detect dementia. Neurology. 2005; 65(4):559-64. doi: 10.1212/01.wnl.0000172958.95282.2a PMID: 16116116.
30. Lezak MD, Howiesen DB, Loring DW. Neuropsychological assessment. 4th ed. New York: Oxford University Press; 2004.
31. Sullivan FM, Treweek S, Grant A, Daly F, Nicolson D, McKinstry B, et al. Improving recruitment to clinical trials with a register of a million patients who agree to the use of their clinical records for research in the Scottish Health Research Register (SHARE). Trials. 2011; 12(Suppl 1):A115.
32. Hunter Medical Research Institute. Research Register. Available from: http://www.hmri.com.au/support/volunteer/research-register/.
33. Beaton SJ, Sperl-Hillen JM, Von Worley A, Fernandes OD, Baurner D, Hanson AM, et al. A comparative analysis of recruitment methods used in a randomized trial of diabetes education interventions. Contemp Clin Trials. 2010; 31(6):549-57. doi: 10.1016/j.cct.2010.08.005 PMID: WOS:000284298400009.
34. Mathur R, Bhaskaran K, Chaturvedi N, Leon DA, vanStaa T, Grundy E, et al. Completeness and usability of ethnicity data in UK-based primary care and hospital databases. Journal of public health. 2014; 36 (4):684-92. doi: 10.1093/pubmed/fdt116 PMID: 24323951; PubMed Central PMCID: PMC4245896.
35. Khadjesari Z, Marston L, Petersen I, Nazareth I, Walters K. Alcohol consumption screening of newlyregistered patients in primary care: a cross-sectional analysis. The British journal of general practice: the journal of the Royal College of General Practitioners. 2013; 63(615):e706-12. doi: 10.3399/bjgp13X673720 PMID: 24152486; PubMed Central PMCID: PMC3782804.
36. Douglas L, Szatkowski L. Socioeconomic variations in access to smoking cessation interventions in UK primary care: insights using the Mosaic classification in a large dataset of primary care records. BMC public health. 2013; 13:546. doi: 10.1186/1471-2458-13-546 PMID: 23738743; PubMed Central PMCID: PMC3710237.
37. Wang Y, O'Donnell CA, Mackay DF, Watt GC. Practice size and quality attainment under the new GMS contract: a cross-sectional analysis. The British journal of general practice: the journal of the Royal College of General Practitioners. 2006; 56(532):830-5. PMID: 17132349; PubMed Central PMCID: PMC1927090.